Could Nixing Race-Adjustments for eGFR Harm Black Cancer Patients?
Removing race from estimated glomerular filtration rate (eGFR) equations would result in fewer Black patients being eligible for certain anticancer drugs, researchers have demonstrated. Their analysis showed that for Black patients, removing race from the Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation reduced median eGFR from 103 mL/min to 89 mL/min. In addition, removing the race […]
Suicidality in Black Youth; Win for Schizo Agent; COVID Leaves Teens Hopeless
Compared with white peers, Black youth under the age of 13 have double the rate of suicide. On top of that, the rate of Black youth who contemplated suicide rose in the past decade from 12.95% to 16.89%. “Applying the white-centric lens that has driven existing suicide research is not sufficient to solving the increasing […]
Early Promise for Pembrolizumab Plus Chemo in RR Hodgkin’s Lymphoma
A chemoimmunotherapy regimen led to a 100% response rate as second-line therapy for relapsed/refractory (RR) classical Hodgkin lymphoma (cHL), a small phase II trial showed. All 38 evaluable patients achieved objective responses with the combination of pembrolizumab (Keytruda), gemcitabine, vinorelbine, and liposomal doxorubicin (P-GVD), including complete responses in 36 of 38 cases. All but two […]